Skip to main content

Johns Hopkins UniversityEst. 1876

America’s First Research University

Archived articles

School of Public Health

Q+A
Why it's time to upgrade to an N95 or KN95 mask
Published Jan 25, 2022
Better masks are needed to protect against the highly transmissible omicron variant, says Bloomberg School expert Chris Beyrer, who also discusses proper mask care and when it's time to throw your mask away
Health Policy Forum
CMS administrator discusses pandemic 'inflection point'
Published Jan 13, 2022 Video
Chiquita Brooks-LaSure spoke Friday as part of the university's Health Policy Forum series
COVID-19
Should omicron close schools?
Published Jan 12, 2022
Experts from across Johns Hopkins weigh in on best practices for students, teachers, and families
Q+A
Yes, you should get a booster
Published Jan 11, 2022
From preventing COVID-19 altogether to lessening symptoms and transmission with breakthrough infections, there are several good reasons to get an mRNA booster ASAP
Safely handling new technologies
Published Jan 11, 2022
Online training modules will focus on the safe development and use of emerging tech such as additive manufacturing, disinfection tech, nanobiotechnology, and e-cigarettes
Q+A
Making sense of the messiness of omicron
Published Jan 10, 2022
In this Q+A, experts from the Johns Hopkins Bloomberg School of Public Health address some common questions and scenarios with what is known right now
Tom Inglesby joins White House COVID-19 Response Team
Published Jan 7, 2022
Inglesby previously served as senior policy adviser for COVID-19 response for the secretary of U.S. Health and Human Services
Coronavirus
Early dose of convalescent plasma may help COVID-19 patients avoid hospitalization
Published Jan 5, 2022
Nationwide, multicenter clinical trial led by Johns Hopkins shows convalescent plasma works as an early treatment for COVID-19, reducing need for hospitalization by 50%
Q+A
Omicron tests the limits of COVID-19 testing
Published Dec 22, 2021
The U.S. is still on its heels when it comes to COVID-19 testing. Will mailing free at-home tests make a difference? Immunologist Gigi Gronvall explains
Q+A
Without global vaccinations, further variants ahead
Published Dec 21, 2021
Vaccine experts Anna Durbin and William Moss explain how vaccination prevents viral mutation, discuss remaining barriers to global vaccine access